Deutsche Bank Maintains Hold on CVS Health, Lowers Price Target to $63
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst George Hill maintains a Hold rating on CVS Health (NYSE:CVS) and lowers the price target from $64 to $63.

August 09, 2024 | 4:58 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Deutsche Bank analyst George Hill maintains a Hold rating on CVS Health and lowers the price target from $64 to $63.
The Hold rating suggests a neutral stance, and the slight reduction in the price target indicates a minor negative adjustment in expectations. This is likely to have a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100